静脉注射4 mg昂丹司琼后QT延长、尖端扭转型室速及心脏骤停
本文报告一例41岁女性酒精使用障碍患者,因恶心、呕吐和上腹痛就诊急诊科,接受4 mg静脉昂丹司琼后1分钟心电图显示室性早搏伴QTc=653 ms,13分钟后发生尖端扭转型室速和心脏骤停,经心肺复苏、静脉肾上腺素和1分钟时成功除颤后恢复,随后给予静脉镁剂。院前实验室检查显示低钾血症(3.2 mEq/L)、低镁血症(1.3 mg/dL)和脂肪酶升高(4918 IU/L)。患者12小时内ECG间期完全正常化并神经功能完好出院。作者认为高危患者接受小剂量昂丹司琼可能发生QT延长、尖端扭转型室速和心脏骤停,需进一步研究确定急诊科最安全的止吐药。
要点
- 41岁女性酒精使用障碍患者接受4 mg静脉昂丹司琼后1分钟心电图QTc=653 ms,13分钟后发生尖端扭转型室速和心脏骤停。
- 该患者实验室检查显示低钾血症(3.2 mEq/L)、低镁血症(1.3 mg/dL)和脂肪酶升高(4918 IU/L)。
- 心脏骤停后经立即心肺复苏、静脉肾上腺素和1分钟时成功除颤,随后给予静脉镁剂,12小时内ECG间期完全正常化。
- 18个月后患者因复发性胰腺炎和类似电解质异常再次就诊,当时避免使用QT延长药物,病程无并发症。
- 作者认为高危患者接受小剂量昂丹司琼可能发生QT延长、尖端扭转型室速和心脏骤停,需进一步研究确定急诊科最安全的止吐药。
适用人群与场景
- 急诊科因恶心、呕吐和上腹痛就诊的患者,尤其是有酒精使用障碍、电解质异常(低钾血症、低镁血症)等高危因素者。
处置流程与药物剂量
- 患者接受4 mg静脉昂丹司琼、30 mg静脉酮咯酸,并接受心电监护。
- 发生尖端扭转型室速和心脏骤停后,立即行心肺复苏和静脉肾上腺素,1分钟时成功除颤,随后给予静脉镁剂。
红旗征与不能漏的情况
- 接受4 mg静脉昂丹司琼后1分钟心电图显示室性早搏伴QTc=653 ms,13分钟后发生尖端扭转型室速和心脏骤停。
- 低钾血症(3.2 mEq/L)、低镁血症(1.3 mg/dL)和脂肪酶升高(4918 IU/L)。
研究设计与关键结果
- 病例报告:41岁女性酒精使用障碍患者,无用药或补充剂史,因恶心、呕吐和上腹痛1天就诊,脉搏77次/分,上腹压痛。
- 接受4 mg静脉昂丹司琼后1分钟心电图显示室性早搏伴QTc=653 ms,13分钟后发生尖端扭转型室速和心脏骤停。
- 经立即心肺复苏、静脉肾上腺素和1分钟时成功除颤,随后给予静脉镁剂;院后心电图显示立即和院后3小时QTc持续延长。
- 院前实验室检查显示低钾血症(3.2 mEq/L)、低镁血症(1.3 mg/dL)和脂肪酶升高(4918 IU/L);未再使用其他QT延长药物。
- 经胸超声心动图和肌钙蛋白正常;ECG间期在12小时内完全正常化,患者神经功能完好出院。
- 18个月后患者因复发性胰腺炎和类似电解质异常返回,当时避免使用QT延长药物,病程无并发症。
证据类型、等级与局限
- 病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为高危患者接受小剂量昂丹司琼可能发生QT延长、尖端扭转型室速和心脏骤停。
- 作者认为需进一步研究确定急诊科最安全的止吐药。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Ondansetron is a commonly used antiemetic in the emergency department despite a 2011 FDA warning regarding dose-related QTc prolongation and torsades des pointes (TdP). Cases of TdP from small ondansetron doses administered in the emergency department are lacking. A 41-year-old-woman with alcohol use disorder on no medications or supplements presented to an emergency department with one day of nausea, vomiting, and epigastric pain. Examination revealed a pulse of 77 beats/min and epigastric tenderness. The patient received 4 mg IV ondansetron, 30 mg IV ketorolac, and was placed on cardiac monitoring. ECG obtained one minute after ondansetron demonstrated premature ventricular contractions with QTc = 653 ms. Thirteen minutes after receiving ondansetron she suffered TdP and cardiac arrest. She received immediate CPR and IV epinephrine with successful defibrillation at one minute. She then received IV magnesium. Post-arrest ECGs demonstrated persistent QTc prolongation immediately and at three hours post-arrest. Laboratory studies, drawn prior to arrest, demonstrated hypokalemia (3.2 mEq/L), hypomagnesemia (1.3 mg/dL), and elevated lipase (4918 IU/L). She received no additional QT-prolonging agents. Transthoracic echocardiogram and troponins were normal; ECG intervals completely normalized within 12 h and she was discharged neurologically intact. The patient returned 18 months later with recurrent pancreatitis and similar electrolyte abnormalities; QT-prolonging drugs were avoided at that time and her course was uncomplicated. QT prolongation with subsequent torsades des pointes and cardiac arrest may occur in high-risk patients receiving small doses of ondansetron. Further studies are warranted to determine the safest antiemetic for use in the emergency department.
参考来源
- Orozco BS, Lee SC, Fuchs RT, et al. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron. Am J Emerg Med. 2023. PMID: 37085406. doi:10.1016/j.ajem.2023.04.003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。